Wen Sha - Absci Corp Chief Staff

ABSI Stock  USD 4.02  0.81  25.23%   

Executive

Wen Sha is Chief Staff of Absci Corp
Address 18105 SE Mill Plain Boulevard, Vancouver, WA, United States, 98683
Phone360 949 1041
Webhttps://www.absci.com

Absci Corp Management Efficiency

The company has return on total asset (ROA) of (0.274) % which means that it has lost $0.274 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4911) %, meaning that it created substantial loss on money invested by shareholders. Absci Corp's management efficiency ratios could be used to measure how well Absci Corp manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.69. The current Return On Capital Employed is estimated to decrease to -0.65. As of now, Absci Corp's Total Current Assets are increasing as compared to previous years. The Absci Corp's current Intangibles To Total Assets is estimated to increase to 0.23, while Non Current Assets Total are projected to decrease to under 89.1 M.
Absci Corp currently holds 15.96 M in liabilities with Debt to Equity (D/E) ratio of 0.07, which may suggest the company is not taking enough advantage from borrowing. Absci Corp has a current ratio of 7.05, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Absci Corp's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

EXECUTIVE Age

John CavanHepion Pharmaceuticals
66
Terry MDSana Biotechnology
57
David HallettRecursion Pharmaceuticals
55
Cindy AtwellPrecision BioSciences
N/A
Prof MDDay One Biopharmaceuticals
55
Adam DubowDay One Biopharmaceuticals
57
Patrick MayoHepion Pharmaceuticals
N/A
RPh PharmDAffimed NV
40
Michael WolfAffimed NV
57
Verender BadialZura Bio Limited
52
Gary WhaleZura Bio Limited
50
Lauren MBADay One Biopharmaceuticals
48
Mark MBAX4 Pharmaceuticals
60
Maurissa MessierPrecision BioSciences
N/A
Edward RebarSana Biotechnology
56
Arndt MDAffimed NV
58
Mahesh PadvalRelay Therapeutics
N/A
Jim WattersRelay Therapeutics
N/A
Reigin ZawadzkiCaribou Biosciences
N/A
John MDSana Biotechnology
N/A
Robin AndrulevichSana Biotechnology
58
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington. Absci Corp operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 211 people. Absci Corp (ABSI) is traded on NASDAQ Exchange in USA. It is located in 18105 SE Mill Plain Boulevard, Vancouver, WA, United States, 98683 and employs 155 people. Absci Corp is listed under Biotechnology category by Fama And French industry classification.

Management Performance

Absci Corp Leadership Team

Elected by the shareholders, the Absci Corp's board of directors comprises two types of representatives: Absci Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Absci. The board's role is to monitor Absci Corp's management team and ensure that shareholders' interests are well served. Absci Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Absci Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
Sean McClain, CEO, Founder
CPA CPA, Chief Officer
Christian MBA, Senior Creation
Shelby JD, Chief Officer
Karin Wierinck, Chief Officer
Sarah JD, Chief Sec
Jens Plassmeier, Senior Technology
Todd CPA, Senior Officer
Melissa Patterson, Chief Staff
Jonathan MS, VP Informatics
Zachariah Jonasson, Chief CFO
Alexander CPA, VP Relations
DVM MBA, Senior Strategy
Denise Dettore, Chief Officer
Andreas Busch, Chief Officer
Thomas JD, VP Property
Amaro TaylorWeiner, Chief Officer
Wen Sha, Chief Staff
Jack Gold, Chief Officer

Absci Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Absci Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

When determining whether Absci Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Absci Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Absci Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Absci Corp Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Absci Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
For more detail on how to invest in Absci Stock please use our How to Invest in Absci Corp guide.
You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Absci Corp. If investors know Absci will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Absci Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.93)
Revenue Per Share
0.04
Quarterly Revenue Growth
1.286
Return On Assets
(0.27)
Return On Equity
(0.49)
The market value of Absci Corp is measured differently than its book value, which is the value of Absci that is recorded on the company's balance sheet. Investors also form their own opinion of Absci Corp's value that differs from its market value or its book value, called intrinsic value, which is Absci Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Absci Corp's market value can be influenced by many factors that don't directly affect Absci Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Absci Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Absci Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Absci Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.